MedCity News October 25, 2024
Katie Adams

This week at HLTH, Dexcom COO Jake Leach discussed Stelo, his company’s new product. Stelo is an over-the-counter continuous glucose monitor meant for all adults who don’t take insulin.

The U.S. spends $413 billion dollars each year on diabetes-related care, meaning that diabetic patients now account for one of every four healthcare dollars spent in the country.

The first step in fixing this problem is increasing people’s awareness of metabolic health and ensuring they’re educated about the choices they can make to better manage their glucose levels, said Dexcom COO Jake Leach during an interview this week at HLTH in Las Vegas.

If people are aware of the role they can play in improving their own metabolic health, they can...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Conferences / Podcast, Digital Health, Technology, Trends, Wearables
Related Articles:
How Digital Health Tools, AI, and Wearables are Transforming Care and Self-Management
ŌURA Promises Relentless Innovation As It Hits New Oura Ring Milestone
FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients
B2B Wearables: A New Tool for Businesses to Promote Workplace Wellness
Q&A: Continuous health monitoring with wearables

Share This Article